Alliancebernstein L.P. Alkermes Plc. Transaction History

Alliancebernstein L.P.

  • $287 Billion
  • Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Alkermes Plc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 709,131 shares of ALKS stock, worth $21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
709,131
Previous 541,345 30.99%
Holding current value
$21 Million
Previous $13 Million 52.14%
% of portfolio
0.01%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.01 - $28.55 $3.86 Million - $4.79 Million
167,786 Added 30.99%
709,131 $19.8 Million
Q2 2024

Aug 14, 2024
BUY
$23.21 - $27.24 $1.67 Million - $1.96 Million
71,842 Added 15.3%
541,345 $13 Million
Q1 2024

May 14, 2024
BUY
$26.4 - $32.56 $5.46 Million - $6.73 Million
206,809 Added 78.73%
469,503 $12.7 Million
Q4 2023

Feb 14, 2024
SELL
$23.37 - $28.68 $6.88 Million - $8.44 Million
-294,322 Reduced 52.84%
262,694 $7.29 Million
Q3 2023

Nov 14, 2023
SELL
$27.17 - $31.97 $5.96 Million - $7.01 Million
-219,194 Reduced 28.24%
557,016 $15.6 Million
Q2 2023

Aug 15, 2023
BUY
$28.34 - $33.63 $9.25 Million - $11 Million
326,225 Added 72.5%
776,210 $24.3 Million
Q1 2023

May 15, 2023
BUY
$25.31 - $29.02 $6.44 Million - $7.38 Million
254,404 Added 130.08%
449,985 $12.7 Million
Q4 2022

Feb 14, 2023
BUY
$21.94 - $26.24 $10,970 - $13,120
500 Added 0.26%
195,581 $5.11 Million
Q1 2022

May 13, 2022
SELL
$23.07 - $27.99 $874,353 - $1.06 Million
-37,900 Reduced 16.27%
195,081 $5.13 Million
Q4 2021

Feb 14, 2022
BUY
$21.47 - $32.08 $768,626 - $1.15 Million
35,800 Added 18.16%
232,981 $5.42 Million
Q3 2021

Nov 10, 2021
SELL
$23.37 - $32.13 $32,718 - $44,982
-1,400 Reduced 0.71%
197,181 $6.08 Million
Q2 2021

Jul 30, 2021
BUY
$18.78 - $25.15 $2.35 Million - $3.15 Million
125,155 Added 170.45%
198,581 $4.87 Million
Q1 2021

May 06, 2021
BUY
$18.21 - $23.2 $7,284 - $9,280
400 Added 0.55%
73,426 $1.37 Million
Q4 2020

Feb 08, 2021
SELL
$15.39 - $22.1 $17,698 - $25,415
-1,150 Reduced 1.55%
73,026 $1.46 Million
Q3 2020

Nov 12, 2020
SELL
$16.16 - $20.66 $169,680 - $216,930
-10,500 Reduced 12.4%
74,176 $1.23 Million
Q2 2020

Aug 13, 2020
SELL
$13.31 - $19.41 $74,536 - $108,696
-5,600 Reduced 6.2%
84,676 $1.64 Million
Q1 2020

May 14, 2020
SELL
$13.06 - $21.24 $26,120 - $42,480
-2,000 Reduced 2.17%
90,276 $1.3 Million
Q4 2019

Feb 18, 2020
BUY
$17.29 - $21.74 $132,147 - $166,158
7,643 Added 9.03%
92,276 $1.88 Million
Q3 2019

Nov 14, 2019
BUY
$19.51 - $24.28 $39 - $48
2 Added 0.0%
84,633 $1.65 Million
Q2 2019

Aug 14, 2019
SELL
$21.47 - $37.33 $8,201 - $14,260
-382 Reduced 0.45%
84,631 $1.91 Million
Q1 2019

May 14, 2019
SELL
$28.4 - $36.49 $39,674 - $50,976
-1,397 Reduced 1.62%
85,013 $3.1 Million
Q4 2018

Feb 13, 2019
SELL
$27.94 - $44.61 $50,180 - $80,119
-1,796 Reduced 2.04%
86,410 $2.55 Million
Q3 2018

Nov 08, 2018
SELL
$38.6 - $46.12 $128,769 - $153,856
-3,336 Reduced 3.64%
88,206 $3.74 Million
Q2 2018

Aug 13, 2018
SELL
$40.56 - $51.36 $187,306 - $237,180
-4,618 Reduced 4.8%
91,542 $3.77 Million
Q1 2018

May 14, 2018
SELL
$53.61 - $67.26 $73,445 - $92,146
-1,370 Reduced 1.4%
96,160 $5.57 Million
Q4 2017

Feb 13, 2018
SELL
$47.69 - $55.39 $1.91 Million - $2.22 Million
-40,110 Reduced 29.14%
97,530 $5.34 Million
Q3 2017

Nov 13, 2017
BUY
$49.16 - $54.45 $6.77 Million - $7.49 Million
137,640
137,640 $7 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.87B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email